These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ADHD, values, and the self. Litton P Am J Bioeth; 2005; 5(3):65-7; discussion W10-2. PubMed ID: 16006360 [No Abstract] [Full Text] [Related]
3. Splitting the self: the not-so-subtle consequences of medicating boys for ADHD. White GB Am J Bioeth; 2005; 5(3):57-9. PubMed ID: 16006364 [No Abstract] [Full Text] [Related]
4. Beyond "real boys" and back to parental obligations. Hughes J Am J Bioeth; 2005; 5(3):61-2; discussion W10-2. PubMed ID: 16006373 [No Abstract] [Full Text] [Related]
5. Will the "real boy" please behave: dosing dilemmas for parents of boys with ADHD. Singh I Am J Bioeth; 2005; 5(3):34-47. PubMed ID: 16006369 [TBL] [Abstract][Full Text] [Related]
6. Expanding the repertoire of bioethics: what next? Perring C Am J Bioeth; 2005; 5(3):63-5; discussion W10-2. PubMed ID: 16006359 [No Abstract] [Full Text] [Related]
7. Beyond creativity: ADHD drug therapy as a moral damper on a child's future success. Krautkramer CJ Am J Bioeth; 2005; 5(3):52-3. PubMed ID: 16006377 [No Abstract] [Full Text] [Related]
8. Authentic faux diamonds and attention deficit disorder. Anijar K; Gabbard D Am J Bioeth; 2005; 5(3):67-70. PubMed ID: 16006371 [No Abstract] [Full Text] [Related]
9. Real impairments, real treatments. Kramer PD Am J Bioeth; 2005; 5(3):62-3; discussion W10-2. PubMed ID: 16006347 [No Abstract] [Full Text] [Related]
10. 'Real' ethics for 'real' boys: context and narrative in bioethics. Hoffmaster B Am J Bioeth; 2005; 5(3):50-1; discussion W10-2. PubMed ID: 16006351 [No Abstract] [Full Text] [Related]
11. ADHD. Taylor E Am J Bioeth; 2005; 5(3):W17. PubMed ID: 16006370 [No Abstract] [Full Text] [Related]
12. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges. Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546 [TBL] [Abstract][Full Text] [Related]
14. [Central nervous system stimulants in AD/HD in adults]. Aanonsen NO; Lensing MB; Mathiesen T Tidsskr Nor Laegeforen; 1999 Jan; 119(1):82-3. PubMed ID: 10025211 [No Abstract] [Full Text] [Related]
15. [Central nervous system stimulants in adults with AD/HD]. Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G Tidsskr Nor Laegeforen; 1999 Jan; 119(3):410. PubMed ID: 10074845 [No Abstract] [Full Text] [Related]
16. Preschool meds: the first clinical trial examining the effects of generic Ritalin on 3- to 5-year-old subjects raises questions not only about the safety of the drug but also about the ethics of testing on ever younger brains. Stolberg SG N Y Times Mag; 2002 Nov; ():58-61. PubMed ID: 17080573 [No Abstract] [Full Text] [Related]
17. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689 [No Abstract] [Full Text] [Related]
18. A reply to critics of using stimulants to treat attention deficit hyperactivity disorder. Pliszka SR Tex Med; 1991 Apr; 87(4):84-7. PubMed ID: 1674631 [TBL] [Abstract][Full Text] [Related]
19. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
20. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Diller LH Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521 [No Abstract] [Full Text] [Related] [Next] [New Search]